The Moat Index

Escalon Medical Corp.

ESMC · Healthcare · $1.5M mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

43/ 100
Shallow moat

The four filters

Pricing power75

Median gross margin 44.9% over 10y, very stable.

Returns on capital11

Median ROIC -26.8%, above the 9% hurdle in 30% of years.

Balance-sheet safety37

Net debt/EBITDA n/ax, interest coverage 6x.

Capital discipline47

Owner earnings trend unclear, share count shrinking (buybacks).

Margin of safety

Above valueOn sale
101% above value
Owner earnings (normalized)
$66513
Est. intrinsic value / share
$0.10
Recent price
$0.20
Discount to value
101% above value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for ESMC yet — it appears once ingest has processed its filings.

Moat Score history

2 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale42.6 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — ESMC has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#208 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #206AVTX Avalo Therapeutics, Inc.42.9 out of 100, Shallow moatShallow moat
  2. #207KEQU Kewaunee Scientific Corporation42.7 out of 100, Shallow moatShallow moat
  3. #209VERU VERU INC.42.6 out of 100, Shallow moatShallow moat
  4. #210IONS IONIS PHARMACEUTICALS, INC.42.6 out of 100, Shallow moatShallow moat

Compare ESMC with its nearest peersAll Healthcare companies on the Index →

Common questions about ESMC

Does Escalon Medical Corp. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores Escalon Medical Corp. (ESMC) 42.6 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 75, returns on capital 11, balance-sheet safety 37, capital discipline 47.
Is ESMC stock trading below its intrinsic value?
Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $0.10 per share versus a recent price of $0.20 — 101% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has ESMC's Moat Score changed over time?
The record logs 2 readings since Jul 17, 2026; the latest reads 42.6 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows ESMC’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/ESMC"
  width="340" height="150" style="border:0"
  title="ESMC Moat Score — The Moat Index"
  loading="lazy"></iframe>
Escalon Medical Corp. (ESMC) Moat Score — The Moat Index · Buy Like Buffett